IFNA1 and neoplasm: Several factors are required for effective anti-tumor immunity: presence of immune effector cells, recognizable tumor antigens, and intact interferon (IFN) signaling pathways, including transcription of the antigen processing machinery (APM; Fig. 1) required for processing and presentation of tumor antigens to cytotoxic T cells.